Lifecare AS

Oslo Stock Exchange LIFE.OL

Lifecare AS EBITDA Margin for the year ending December 31, 2023: -245.26%

Lifecare AS EBITDA Margin is -245.26% for the year ending December 31, 2023, a -180.40% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Lifecare AS EBITDA Margin for the year ending December 31, 2022 was -87.47%, a 98.16% change year over year.
Lifecare AS EBITDA Margin for the year ending December 31, 2021 was -4,741.32%, a -2,963.06% change year over year.
Lifecare AS EBITDA Margin for the year ending December 31, 2020 was -154.79%, a 51.00% change year over year.
Lifecare AS EBITDA Margin for the year ending December 31, 2019 was -315.92%, a -26.57% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Oslo Stock Exchange: LIFE.OL

Lifecare AS

CEO	Mr. Joacim Holter
IPO Date	July 11, 2018
Location	Norway
Headquarters	Ytrebygdsvegen 215
Employees	32
Sector	Healthcare
Industries Medical Instruments 3D Printing Autonomous Driving Biotechnology Clinical Trials Hardware & Electronics Pharmaceuticals Telehealth

Description

Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. The company was founded in 2006 and is headquartered in Bergen, Norway.

Key trends

Past 5 years